New Issue: Credit Suisse prices $382,000 of 8.5% reverse convertibles linked to Boston Scientific

By Laura Lutz

Des Moines, Sept. 29 - Credit Suisse (USA) Inc. priced a $382,000 issue of 8.5% reverse convertible securities due Sept. 28, 2007 linked to Boston Scientific Corp. common stock, according to a 424B2 filing with the Securities and Exchange Commission.

The payout at maturity will be par unless Boston Scientific stock falls below the knock-in price during the life of the notes and finishes below its initial price on Sept. 24, 2007, the valuation date, in which case the payout will be a number of Boston Scientific shares equal to $1,000 divided by the initial share price.

Issuer:	Credit Suisse (USA) Inc.
Issue:	Reverse convertible securities
Amount:	$382,000
Underlying stock:	Boston Scientific Corp.
Maturity:	Sept. 28, 2007
Coupon:	8.5%, payable quarterly
Price:	Par
Payout at maturity:	Par unless Boston Scientific stock falls below knock-in price of $10.36 during the life of the notes and finishes below its initial value, in which case payout will be 67.5676 shares of Boston Scientific stock
Initial share level:	$14.80
Knock-in price:	$10.36, 70% of initial price
Pricing date:	Sept. 26
Settlement date:	Sept. 29
Underwriter:	Credit Suisse Securities (USA) LLC
Agents' fee:	$28.10 per $1,000 principal amount

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.